Alpha Cubed Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Alpha Cubed Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-269	Closed	-$283K	–	287
2024 Q3	$283K	Sell	269 -27	-9%	-$30K	0.01%	208
2024 Q2	$311K	Sell	296 -75	-20%	-$72.7K	0.01%	208
2024 Q1	$357K	Buy	+371	New	+$353K	0.02%	184
2022 Q1	–	Sell	-388	Closed	-$245K	–	348
2021 Q4	$245K	Buy	388 +39	+11%	+$24K	0.02%	239
2021 Q3	$211K	Sell	349 -20	-5%	-$12.4K	0.02%	244
2021 Q2	$206K	Buy	+369	New	+$187K	0.01%	253

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alpha Cubed Investments's REGN Position: Q4 2024 in Review

Alpha Cubed Investments sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 269 shares — an estimated $283K sold.

Alpha Cubed Investments first reported a position in REGN in Q2 2021 and held it in 6 quarters. The position peaked at $357K in Q1 2024. 1,320 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

Alpha Cubed Investments reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Alpha Cubed Investments sold 269 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $283K.
Alpha Cubed Investments first reported a position in Regeneron Pharmaceuticals in Q2 2021 and held it in 6 quarters.
Alpha Cubed Investments's Regeneron Pharmaceuticals position peaked at $357K in Q1 2024.
1,320 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Alpha Cubed Investments's 13F filing for Q4 2024, filed 17 Jan 2025.